BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

776 related articles for article (PubMed ID: 26996256)

  • 21. The Revolution Continues: Newly Discovered Systems Expand the CRISPR-Cas Toolkit.
    Murugan K; Babu K; Sundaresan R; Rajan R; Sashital DG
    Mol Cell; 2017 Oct; 68(1):15-25. PubMed ID: 28985502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene editing and clonal isolation of human induced pluripotent stem cells using CRISPR/Cas9.
    Yumlu S; Stumm J; Bashir S; Dreyer AK; Lisowski P; Danner E; Kühn R
    Methods; 2017 May; 121-122():29-44. PubMed ID: 28522326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR-Cas9-Mediated Genome Editing and Transcriptional Control in Yarrowia lipolytica.
    Schwartz C; Wheeldon I
    Methods Mol Biol; 2018; 1772():327-345. PubMed ID: 29754237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small Molecules for Enhancing the Precision and Safety of Genome Editing.
    Shin S; Jang S; Lim D
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-viral and viral delivery systems for CRISPR-Cas9 technology in the biomedical field.
    He ZY; Men K; Qin Z; Yang Y; Xu T; Wei YQ
    Sci China Life Sci; 2017 May; 60(5):458-467. PubMed ID: 28527117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct Generation of Conditional Alleles Using CRISPR/Cas9 in Mouse Zygotes.
    Pritchard CEJ; Kroese LJ; Huijbers IJ
    Methods Mol Biol; 2017; 1642():21-35. PubMed ID: 28815491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-Throughput Approaches to Pinpoint Function within the Noncoding Genome.
    Montalbano A; Canver MC; Sanjana NE
    Mol Cell; 2017 Oct; 68(1):44-59. PubMed ID: 28985510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methods for decoding Cas9 protospacer adjacent motif (PAM) sequences: A brief overview.
    Karvelis T; Gasiunas G; Siksnys V
    Methods; 2017 May; 121-122():3-8. PubMed ID: 28344037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards mastering CRISPR-induced gene knock-in in plants: Survey of key features and focus on the model Physcomitrella patens.
    Collonnier C; Guyon-Debast A; Maclot F; Mara K; Charlot F; Nogué F
    Methods; 2017 May; 121-122():103-117. PubMed ID: 28478103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Building Cre Knockin Rat Lines Using CRISPR/Cas9.
    Ma Y; Zhang L; Huang X
    Methods Mol Biol; 2017; 1642():37-52. PubMed ID: 28815492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CRISPR-Cas9 system-driven site-specific selection pressure on Herpes simplex virus genomes.
    Li Z; Bi Y; Xiao H; Sun L; Ren Y; Li Y; Chen C; Cun W
    Virus Res; 2018 Jan; 244():286-295. PubMed ID: 28279800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methods for Optimizing CRISPR-Cas9 Genome Editing Specificity.
    Tycko J; Myer VE; Hsu PD
    Mol Cell; 2016 Aug; 63(3):355-70. PubMed ID: 27494557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineering the Delivery System for CRISPR-Based Genome Editing.
    Glass Z; Lee M; Li Y; Xu Q
    Trends Biotechnol; 2018 Feb; 36(2):173-185. PubMed ID: 29305085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiplexed conditional genome editing with Cas12a in
    Port F; Starostecka M; Boutros M
    Proc Natl Acad Sci U S A; 2020 Sep; 117(37):22890-22899. PubMed ID: 32843348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural Basis for Guide RNA Processing and Seed-Dependent DNA Targeting by CRISPR-Cas12a.
    Swarts DC; van der Oost J; Jinek M
    Mol Cell; 2017 Apr; 66(2):221-233.e4. PubMed ID: 28431230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRISPR Mediated Genome Engineering and its Application in Industry.
    Kaboli S; Babazada H
    Curr Issues Mol Biol; 2018; 26():81-92. PubMed ID: 28879858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of CRISPR/Cas9 for Efficient Genome Editing in Toxoplasma gondii.
    Shen B; Brown K; Long S; Sibley LD
    Methods Mol Biol; 2017; 1498():79-103. PubMed ID: 27709570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pea early-browning virus-mediated genome editing via the CRISPR/Cas9 system in Nicotiana benthamiana and Arabidopsis.
    Ali Z; Eid A; Ali S; Mahfouz MM
    Virus Res; 2018 Jan; 244():333-337. PubMed ID: 29051052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiviral Goes Viral: Harnessing CRISPR/Cas9 to Combat Viruses in Humans.
    Soppe JA; Lebbink RJ
    Trends Microbiol; 2017 Oct; 25(10):833-850. PubMed ID: 28522157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.